BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22846397)

  • 1. In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system.
    Childs TS; Webley WC
    Vaccine; 2012 Sep; 30(41):5942-8. PubMed ID: 22846397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.
    Zhu S; Feng Y; Rao P; Xue X; Chen S; Li W; Zhu G; Zhang L
    Appl Microbiol Biotechnol; 2014 May; 98(9):4107-17. PubMed ID: 24458565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
    Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
    BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis.
    Zhu S; Chen J; Zheng M; Gong W; Xue X; Li W; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):771-8. PubMed ID: 20923859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea.
    Stuart ES; Morshed F; Sremac M; DasSarma S
    J Biotechnol; 2004 Nov; 114(3):225-37. PubMed ID: 15522433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.
    Zheng Y; Zhao WM; Wang H; Zhou YB; Luan Y; Qi M; Cheng YZ; Tang W; Liu J; Yu H; Yu XP; Fan YJ; Yang X
    Biochem Cell Biol; 2007 Apr; 85(2):218-26. PubMed ID: 17534403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloning and expression of Chlamydia trachomatis OmcBc gene and antigenicity analysis of the protein].
    Wang J; Zhang YQ; Zhong GM; Yu P
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1558-61. PubMed ID: 20650765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel chimeric MOMP antigen expressed in Escherichia coli, Arabidopsis thaliana, and Daucus carota as a potential Chlamydia trachomatis vaccine candidate.
    Kalbina I; Wallin A; Lindh I; Engström P; Andersson S; Strid K
    Protein Expr Purif; 2011 Dec; 80(2):194-202. PubMed ID: 21903168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
    Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
    Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
    Andrew DW; Hafner LM; Beagley KW; Timms P
    J Reprod Immunol; 2011 Sep; 91(1-2):9-16. PubMed ID: 21856018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide.
    Taha MA; Singh SR; Dennis VA
    Nanotechnology; 2012 Aug; 23(32):325101. PubMed ID: 22824940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle.
    Sremac M; Stuart ES
    BMC Biotechnol; 2008 Jan; 8():9. PubMed ID: 18237432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mapping of diagnostically important antigenic regions of major outer membrane protein (MOMP) from Chlamydia trachomatis using recombinant proteins with overlapping structures].
    Savel'eva NV; Zagriadskaia IuE; Klimashevskaia SV; Puzyrev VF; Burkov AN; Obriadina AP; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2009; (3):17-21. PubMed ID: 19705778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of recombinant fragments of the major outer-membrane protein of Chlamydia trachomatis: their potential as subunit vaccines.
    Conlan JW; Ferris S; Clarke IN; Ward ME
    J Gen Microbiol; 1990 Oct; 136(10):2013-20. PubMed ID: 1702826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera.
    Sanchez-Campillo M; Bini L; Comanducci M; Raggiaschi R; Marzocchi B; Pallini V; Ratti G
    Electrophoresis; 1999 Aug; 20(11):2269-79. PubMed ID: 10493131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
    J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
    Vasilevsky S; Stojanov M; Greub G; Baud D
    Virulence; 2016; 7(1):11-22. PubMed ID: 26580416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen, Chlamydia trachomatis.
    Allen JE; Stephens RS
    Eur J Immunol; 1993 May; 23(5):1169-72. PubMed ID: 8477811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
    Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF
    Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.